Testing effectiveness (Phase 2)Active Not RecruitingNCT05468073
What this trial is testing
Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
Who this might be right for
Alzheimer Disease
Centre Hospitalier St Anne 40